UNIGE document Scientific Article
previous document  unige:82470  next document
add to browser collection

News in angiology and hemostasis

Published in Revue médicale suisse. 2016, vol. 12, no. 500, p. 13-6
Abstract This update describes contemporary studies of clinical relevance in angiology and hemostasis. We discuss newer developments for the treatment of haemophilia, with a focus on drugs with longer-half lives. Direct anticoagulants (DOAC: rivaroxaban, apixaban, edoxaban and dabigatran) and their approved prescription in Switzerland are summarized, with a description of antidotes that will be available in the near future. We will present new data on the utility of cancer screening at the diagnosis of idiopathic venous thromboembolism (VTE) and on the evaluation of DOAC in patients with cancer-related VTE. Finally, new studies evaluating the clinical risk-benefit of anticoagulation bridging for patients with vitamin K antagonists undergoing procedures do not support the use of such bridging in the majority of patients.
Keywords Anticoagulants/pharmacology/therapeutic useDrug ApprovalHemophilia A/therapyHemostasis/drug effectsHumansSwitzerlandVitamin K/antagonists & inhibitors
PMID: 26946695
Full text
Article (Published version) (547 Kb) - public document Free access
Research groups Anatomie clinique (134)
Geneva Platelet Group (13)
La maladie thromboembolique veineuse (808)
(ISO format)
BOEHLEN, Françoise, BLONDON, Marc, FONTANA, Pierre. News in angiology and hemostasis. In: Revue médicale suisse, 2016, vol. 12, n° 500, p. 13-6. https://archive-ouverte.unige.ch/unige:82470

437 hits



Deposited on : 2016-04-08

Export document
Format :
Citation style :